nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Myeloid Leukemia Secondary to Oxaliplatin Treatment for Esophageal Cancer
|
Damodaran, Senthilkumar |
|
2012 |
11 |
2 |
p. 151-154 4 p. |
artikel |
2 |
A Retrospective Study of Treatment Outcomes in Patients With Carcinoma of Unknown Primary Site and a Colorectal Cancer Molecular Profile
|
Hainsworth, John D. |
|
2012 |
11 |
2 |
p. 112-118 7 p. |
artikel |
3 |
Clinical Decision Aids in Colon Cancer: A Comparison of Two Predictive Nomograms
|
Collins, Ian M. |
|
2012 |
11 |
2 |
p. 138-142 5 p. |
artikel |
4 |
Effectiveness of Liver Metastasectomies in Patients With Metastatic Colorectal Cancer Treated With FIr-B/FOx Triplet Chemotherapy Plus Bevacizumab
|
Bruera, Gemma |
|
2012 |
11 |
2 |
p. 119-126 8 p. |
artikel |
5 |
Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity
|
Hoff, Paulo M. |
|
2012 |
11 |
2 |
p. 93-100 8 p. |
artikel |
6 |
Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer
|
Saltz, Leonard |
|
2012 |
11 |
2 |
p. 101-111 11 p. |
artikel |
7 |
Preoperative Radiation Therapy for Upper Rectal CancerT3,T4/Nx: Selectivity Essential
|
Popek, Sarah |
|
2012 |
11 |
2 |
p. 88-92 5 p. |
artikel |
8 |
PTEN Gene Expression and Mutations in the PIK3CA Gene as Predictors of Clinical Benefit to Anti-Epidermal Growth Factor Receptor Antibody Therapy in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
|
Sood, Arjun |
|
2012 |
11 |
2 |
p. 143-150 8 p. |
artikel |
9 |
Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies
|
Sugihara, Kenichi |
|
2012 |
11 |
2 |
p. 127-137 11 p. |
artikel |
10 |
To Give or Not to Give Anti–Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies to Patients With KRAS G13D Mutation in Advanced Colorectal Cancer
|
Kim, Richard |
|
2012 |
11 |
2 |
p. 85-87 3 p. |
artikel |